Filing Flows › cbdMD (YCBD) › Q4 FY24
cbdMD (YCBD) Q4 FY24 earnings results (fourth quarter fiscal 2024)
10-K filed Dec 18, 2024
cbdMD (YCBD) reported revenue of $4.6M for the fourth quarter fiscal 2024 (Q4 FY24), -20% from a year earlier and -12% from the quarter before. Operating margin was -6.9%, net loss $153K (3.4% of revenue).
cbdMD, Q4 FY24: revenue $4.6M (-20% year over year), operating margin -6.9%, net loss $153K, operating cash flow $167K. The chart follows the revenue to costs, profit and cash.
| Q4 FY24 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.6M | -12% | -20% |
| Operating profit | −$317K | — | — |
| Net earnings | −$153K | — | — |
| Operating cash flow | $167K | -42% | — |
| Free cash flow | $157K | -46% | — |
What changed
Revenue was $4.6M in Q4 FY24, down 20% year over year and down 12% from the previous quarter.
Gross margin was 53.9%, down 8.3 points from a year earlier. Operating costs exceeded revenue by $317K, an operating margin of -6.9%. Operating expenses fell 85% while revenue fell 20%. The quarter ended with a net loss of $153K, after a profit of $460K the previous quarter. Non-operating items added $164K, -107% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was $167K. Non-cash charges added back $288K of depreciation and amortization. Working capital and other items added $32K. Capital expenditures of $10K left free cash flow of $157K.
Questions
What was cbdMD's revenue in the fourth quarter fiscal 2024?
cbdMD (YCBD) reported revenue of $4.6M for the fourth quarter fiscal 2024 (Q4 FY24), -20% from a year earlier and -12% from the quarter before.
Was cbdMD profitable in the fourth quarter fiscal 2024?
Operating loss was $317K (-6.9% of revenue) and net loss $153K.
Source: cbdMD 10-K on SEC EDGAR.